Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine crawled time : 00:20 save search
Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial
Published: 2023-06-03 (Crawled : 00:20) - globenewswire.com
EVAX | News | $4.21 2.43% 35K
|
Manufacturing
| Email alert
Add to watchlist
evx-01 melanoma vaccine cancer technology trial
Global Messenger RNA (mRNA) Vaccines & Therapeutics Markets, 2022-2023 & 2028: Rising Demand for Therapeutic Drugs and Vaccines for Ebola, influenza, HIV, and Other Viral Illnesses
Published: 2023-01-06 (Crawled : 00:20) - prnewswire.com
CVAC | $2.44 -5.06% -5.33% 710K
|
Health Technology
| Email alert
Add to watchlist
global therapeutics vaccine hiv
Pfizer and BioNTech's Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster Receives Health Canada Authorization for Children 5 Through <12 Years of Age
Published: 2022-12-09 (Crawled : 00:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
BNTX | $86.19 -0.24% -0.24% 570K
|
Health Technology
|
| O: -0.05%
H: 0.75%
C: -0.83%
covid-19 children vaccine canada health authorization
Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Booster in Adults
Published: 2022-11-18 (Crawled : 00:20) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 2.67%
H: 0.0%
C: -7.89%
covid-19 vaccine canada nuvaxovid authorization
Vaccinex, Inc. to Present at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
Published: 2021-11-09 (Crawled : 00:20) - ir.vaccinex.com
VCNX | $4.71 -2.69% -2.76% 11K
|
Health Technology
|
| O: -0.51%
H: 5.08%
C: 4.06%
disease alzheimer clinical trials vaccine trials trial alzheimer’s alzheimer's disease alzheimer's
The Singapore Tourism Board Announces Country Will Open to Vaccinated U.S. and Canadian Travelers
Published: 2021-10-09 (Crawled : 00:20) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
travel vaccine
Janssen Announces Phase 2b Data Demonstrating its Investigational RSV Adult Vaccine Provided 80% Protection Against Lower Respiratory Infections in Older Adults
Published: 2021-10-02 (Crawled : 00:20) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
phase 2 respiratory vaccine phase 2b injection order infections
Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease
Published: 2021-10-02 (Crawled : 00:20) - globenewswire.com
ADPT | News | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
| Email alert
Add to watchlist
disease biotech vaccine iot injection sars-cov-2 infections
Global Coronavirus (COVID-19) Vaccines Markets, 2019-2020 & 2027: Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed, RNA, DNA, Genetics
Published: 2021-06-04 (Crawled : 00:20) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
| Email alert
Add to watchlist
ARCT 4 | $26.31 -4.81% -5.06% 610K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
| Email alert
Add to watchlist
BNTX | $86.19 -0.24% -0.24% 570K
|
Health Technology
| Email alert
Add to watchlist
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
covid genetic vaccine repurposed
Ministry of Food and Drug Safety of South Korea (MFDS) Authorizes Moderna’s COVID-19 Vaccine
Published: 2021-05-21 (Crawled : 00:20) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 1.78%
H: 0.21%
C: -4.43%
covid food vaccine drug authorized
FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review
Published: 2021-04-23 (Crawled : 00:20) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
covid fda vaccine
Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. for All Adults Aged 18 and Older Following CDC and FDA Decision
Published: 2021-04-23 (Crawled : 00:20) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
covid fda vaccine order
FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review
Published: 2021-04-23 (Crawled : 00:20) - fda.gov
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
covid fda vaccine
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
PRTG | $0.299 35.17% 26.02% 140K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.